ASSET | DATE | % RETURN |
---|---|---|
MDxHealth SA ADR (MDXH) | 10/14/2020 - 10/14/2025 | 419,900% |
Azitra (AZTR) | 10/14/2020 - 10/14/2025 | 12,292.86% |
180 Life Sciences (ATNF) | 10/14/2020 - 10/14/2025 | 6,798.95% |
Regencell Bioscience (RGC) | 10/14/2020 - 10/14/2025 | 5,596.64% |
NewAmsterdam Pharma Company NV Warrant (NAMSW) | 10/14/2020 - 10/14/2025 | 2,641% |
Celcuity LLC (CELC) | 10/14/2020 - 10/14/2025 | 776.34% |
Abivax SA American Depositary Shares (ABVX) | 10/14/2020 - 10/14/2025 | 724.4% |
Merus (MRUS) | 10/14/2020 - 10/14/2025 | 607.84% |
Belite Bio Inc ADR (BLTE) | 10/14/2020 - 10/14/2025 | 538.16% |
Summit Therapeutics (SMMT) | 10/14/2020 - 10/14/2025 | 536.94% |
Catalyst Pharmaceuticals (CPRX) | 10/14/2020 - 10/14/2025 | 531.58% |
ADMA Biologics (ADMA) | 10/14/2020 - 10/14/2025 | 508.79% |
Viking Therapeutics (VKTX) | 10/14/2020 - 10/14/2025 | 461.42% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 10/14/2020 - 10/14/2025 | 423.95% |
Nuvalent (NUVL) | 10/14/2020 - 10/14/2025 | 395.86% |
COSCIENS Biopharma (CSCI) | 10/14/2020 - 10/14/2025 | 366.34% |
Ocugen (OCGN) | 10/14/2020 - 10/14/2025 | 362.96% |
Insmed (INSM) | 10/14/2020 - 10/14/2025 | 354.63% |
Arcellx (ACLX) | 10/14/2020 - 10/14/2025 | 353.84% |
GRAIL, LLC (GRAL) | 10/14/2020 - 10/14/2025 | 314.6% |
Monopar Therapeutics (MNPR) | 10/14/2020 - 10/14/2025 | 308.2% |
United Therapeutics (UTHR) | 10/14/2020 - 10/14/2025 | 306.86% |
Rhythm Pharmaceuticals (RYTM) | 10/14/2020 - 10/14/2025 | 295.18% |
Protagonist Therapeutics (PTGX) | 10/14/2020 - 10/14/2025 | 266.7% |
Mirum Pharmaceuticals (MIRM) | 10/14/2020 - 10/14/2025 | 262.66% |